These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23892243)

  • 21. Interaction Between Alcohol Consumption Patterns, Antiretroviral Therapy Type, and Liver Fibrosis in Persons Living with HIV.
    Bilal U; Lau B; Lazo M; McCaul ME; Hutton HE; Sulkowski MS; Moore RD; Chander G
    AIDS Patient Care STDS; 2016 May; 30(5):200-7. PubMed ID: 27158847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Influencing Antiretroviral Adherence and Virological Outcomes in People Living with HIV in the Highlands of Papua New Guinea.
    Gare J; Kelly-Hanku A; Ryan CE; David M; Kaima P; Imara U; Lote N; Crowe SM; Hearps AC
    PLoS One; 2015; 10(8):e0134918. PubMed ID: 26244516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study.
    Cook RL; Zhou Z; Kelso-Chichetto NE; Janelle J; Morano JP; Somboonwit C; Carter W; Ibanez GE; Ennis N; Cook CL; Cohen RA; Brumback B; Bryant K
    Addict Sci Clin Pract; 2017 Sep; 12(1):22. PubMed ID: 28950912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol consumption and HIV disease progression.
    Samet JH; Cheng DM; Libman H; Nunes DP; Alperen JK; Saitz R
    J Acquir Immune Defic Syndr; 2007 Oct; 46(2):194-9. PubMed ID: 17667330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.
    Peltzer K; Ramlagan S; Khan MS; Gaede B
    SAHARA J; 2011; 8(4):179-86. PubMed ID: 23236959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-retroviral therapy among HIV infected travelers to Hajj pilgrimage.
    Habib AG; Abdulmumini M; Dalhat MM; Hamza M; Iliyasu G
    J Travel Med; 2010; 17(3):176-81. PubMed ID: 20536886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Human Immunodeficiency Virus (HIV) Asymptomatic Status When Starting Antiretroviral Therapy on Adherence and Treatment Outcomes and Implications for Test and Treat: The Swiss HIV Cohort Study.
    Glass TR; Günthard HF; Calmy A; Bernasconi E; Scherrer AU; Battegay M; Steffen A; Böni J; Yerly S; Klimkait T; Cavassini M; Furrer H
    Clin Infect Dis; 2021 Apr; 72(8):1413-1421. PubMed ID: 32157270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
    Salazar-Vizcaya L; Keiser O; Karl Technau ; Davies MA; Haas AD; Blaser N; Cox V; Eley B; Rabie H; Moultrie H; Giddy J; Wood R; Egger M; Estill J
    AIDS; 2014 Oct; 28(16):2451-60. PubMed ID: 25392857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load.
    Phillips AN; Staszewski S; Weber R; Kirk O; Francioli P; Miller V; Vernazza P; Lundgren JD; Ledergerber B; ; ;
    JAMA; 2001 Nov; 286(20):2560-7. PubMed ID: 11722270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.
    Wang L; Min JE; Zang X; Sereda P; Harrigan RP; Montaner JSG; Nosyk B
    Clin Infect Dis; 2017 Oct; 65(9):1496-1503. PubMed ID: 29048508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
    Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.
    Hermans LE; Moorhouse M; Carmona S; Grobbee DE; Hofstra LM; Richman DD; Tempelman HA; Venter WDF; Wensing AMJ
    Lancet Infect Dis; 2018 Feb; 18(2):188-197. PubMed ID: 29158101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lower rates of ART initiation and decreased retention among ART-naïve patients who consume alcohol enrolling in HIV care and treatment programs in Kenya and Uganda.
    Patsis I; Goodrich S; Yiannoutsos CT; Brown SA; Musick BS; Diero L; Kulzer JL; Bwana MB; Oyaro P; Wools-Kaloustian KK
    PLoS One; 2020; 15(10):e0240654. PubMed ID: 33095784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.
    Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P
    Glob Health Action; 2016; 9():29943. PubMed ID: 26765104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assumed infectiousness, treatment adherence and sexual behaviours: applying the Swiss Statement on infectiousness to HIV-positive alcohol drinkers.
    Kalichman SC; Grebler T; Amaral CM; McKerey M; White D; Kalichman MO; Cherry C; Eaton L
    HIV Med; 2013 May; 14(5):263-72. PubMed ID: 23107801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beyond the Brain: The Role of Brain-Derived Neurotrophic Factor in Viroimmune Responses to Antiretroviral Therapy among People Living with HIV with and without Alcohol Use.
    Míguez-Burbano MJ; Espinoza L; Bueno D; Vargas M; Trainor AB; Quiros C; Lewis JE; Asthana D
    J Int Assoc Provid AIDS Care; 2014; 13(5):454-60. PubMed ID: 24835642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptability of obtaining hair samples for assessing antiretroviral therapy (ART) exposure amongst alcohol drinking ART recipients in Tshwane, South Africa.
    Kekwaletswe CT; Nkosi S; Kitleli NB; Myers B; Shuper P; Parry CDH; Morojele NK
    AIDS Care; 2018 Dec; 30(12):1498-1501. PubMed ID: 29779409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study.
    Kan W; Teng T; Liang S; Ma Y; Tang H; Zuohela T; Sun G; He C; Wall KM; Marconi VC; Liao L; Leng X; Liu P; Ruan Y; Xing H; Shao Y
    BMJ Open; 2017 Sep; 7(9):e016012. PubMed ID: 28882911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation and Operational Research: Community-Based Adherence Clubs for the Management of Stable Antiretroviral Therapy Patients in Cape Town, South Africa: A Cohort Study.
    Grimsrud A; Lesosky M; Kalombo C; Bekker LG; Myer L
    J Acquir Immune Defic Syndr; 2016 Jan; 71(1):e16-23. PubMed ID: 26473798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.